Clinical Research Directory
Browse clinical research sites, groups, and studies.
APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia
Sponsor: University of Pennsylvania
Summary
The goal of this clinical trial is to investigate the effects of early initiation of double low-dose aspirin in pregnant women. The main questions it aims to answer are: Does this dose and timing of aspirin reduce the risk of pre-eclampsia compared to standard recommendations? Does this dose and timing of aspirin reduce the risk of pregnancy loss compared to standard recommendations? Participants will begin taking at no later than 6 weeks 6 days gestational age, either 162mg of aspirin through delivery or placebo until 12 weeks and then 81mg of aspirin through delivery.
Key Details
Gender
FEMALE
Age Range
18 Years - 45 Years
Study Type
INTERVENTIONAL
Enrollment
1150
Start Date
2024-06-12
Completion Date
2029-06
Last Updated
2026-01-20
Healthy Volunteers
No
Conditions
Interventions
Aspirin 162 mg
Aspirin is a nonsteroidal anti-inflammatory drug.
Aspirin 81mg
Aspirin is a nonsteroidal anti-inflammatory drug.
Locations (1)
University of Pennsylvania
Philadelphia, Pennsylvania, United States